Skip to content

Clinical trials

Pancreatic Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Country / region: South Korea Clear all

183 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20052
20063
20074
20082
20093
20102
20117
20124
20135
201411
20158
201618
20178
201814
201911
202017
202117
202214
20234
20249
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78
Unknown status45
Recruiting29
Active, not recruiting16
Terminated12
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital22
Yonsei University17
Asan Medical Center12
National Cancer Center, Korea12
Samsung Medical Center9
Eli Lilly and Company6
AstraZeneca5
Revolution Medicines, Inc.4
Ajou University School of Medicine3
Astellas Pharma Global Development, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms183
Colorectal Neoplasms26
Carcinoma, Non-Small-Cell Lung25
Stomach Neoplasms22
Ovarian Neoplasms18
Neoplasms17
Breast Neoplasms14
Cholangiocarcinoma14
Neoplasm Metastasis14
Biliary Tract Neoplasms13

Trials

Showing 1 to 25 of 183. Each trial links to its page on Pharma Observatory.

83 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.